Can premature ovarian failure take youth hormone

Key reminder: If many women find that their menstrual flow is relatively small, they think it is caused by their own qi and blood deficiency, endocrine imbalance, excessive fasting to lose weight, etc. However, if a woman suffers from premature ovarian failure, it is also possible that her menstrual volume will gradually decrease. Therefore, if a woman develops symptoms related to premature ovarian failure, she should go to the hospital for examination in time to determine whether she has premature ovarian failure.

If a woman experiences amenorrhea before the age of 40, she may be suffering from premature ovarian failure. For women with premature ovarian failure, in addition to menopause, patients will also experience different low estrogen symptoms, such as sweating, loss of libido, red cheeks, etc. Premature ovarian failure can have a great impact on women's physical and mental health. Therefore, when women find that they have related symptoms of premature ovarian failure, they should go to the hospital for treatment in time.

In the treatment of premature ovarian failure, the main treatments are estrogen-progesterone replacement therapy, ovulation induction therapy, immunotherapy, DHEA therapy, etc.

For young patients with premature ovarian failure, estrogen and progesterone replacement therapy is very important. Because, after the patient has gone through this type of replacement therapy, the symptoms caused by low estrogen in the patient's body and the shrinkage of the urogenital system can be alleviated. In addition, it can also prevent patients from developing certain complications in the future, such as osteoporosis, Alzheimer's disease, etc. However, if the body uses estrogen replacement therapy for a long time to treat premature ovarian failure, it will also have an impact on the patient's health, such as possibly causing endometrial cancer, breast cancer, etc. Therefore, patients should be extra cautious in choosing treatment methods and carry out necessary tests and telephone follow-up visits.

DHEA therapy is also called dehydroepiandrosterone therapy. In women's bodies, 50% of dehydroepiandrosterone is metabolized by the adrenal reticular zone, 20% is metabolized by the uterus and ovaries, and the remaining 30% is converted from dehydroepiandrosterone. Dehydroepiandrosterone is a key substance for the production of androstenedione, testosterone, and estradiol. The level of dehydroepiandrosterone will affect the metabolism of this growth hormone. Therefore, women can take youth hormones to maintain dehydroepiandrosterone. Youth hormones contain dehydroepiandrosterone, which can achieve the purpose of treating premature ovarian failure after taking them. However, during the period of taking youth hormone, patients should go to the hospital for regular check-ups, and the amount of youth hormone to be taken should be based on the doctor's instructions.